<生产厂家价格>

盐酸法舒地尔

盐酸法舒地尔用途

【用途一】
105628-07-7（盐酸法舒地尔）用于治疗心绞痛

盐酸法舒地尔名称

[ CAS 号 ]:
105628-07-7

[ 中文名 ]:
盐酸法舒地尔

[ 英文名 ]:
Fasudil Hydrochloride

[中文别名 ]:

盐酸法苏地尔

[英文别名 ]:

Eril
MFCD00943198
Fasudil HCl
Fasudil Monohydrochloride
Fasudil Hydrochloride
Fasudil (Hydrochloride)

盐酸法舒地尔生物活性

[ 描述 ]:

Fasudil 是一种有效的 ROCK1,PKA,PKC 和 MLCK 抑制剂,Ki 值分别为 0.33 μM,1.0 μM,9.3 μM 和 55 μM。

[ 相关类别 ]:

信号通路 >> 自噬 >> 自噬

信号通路 >> 蛋白酪氨酸激酶 >> PKA

信号通路 >> 干细胞及 Wnt 通路 >> PKA

信号通路 >> 细胞周期/DNA损伤 >> 岩石

信号通路 >> 干细胞及 Wnt 通路 >> 岩石

信号通路 >> TGF-beta/Smad 信号通路 >> 岩石

研究领域 >> 癌症

[ 靶点 ]

p160ROCK:0.33 μM (Ki)

PKA:1 μM (Ki)

PKC:9.3 μM (Ki)

MLCK:55 μM (Ki)

[体外研究]

法舒地尔盐酸盐具有血管舒张作用,并占据酶结合位点的腺嘌呤口袋[1]。法舒地尔对去极化兔主动脉的Ca2 +诱导的收缩产生竞争性抑制作用。法舒地尔抑制对KCl,苯乙烯(PHE)和前列腺素(PG)F2a的收缩反应[2]。法舒地尔还通过抑制5-羟色胺,去甲肾上腺素,组胺,血管紧张素和多巴胺诱导的螺旋条收缩而表现出血管舒张作用[3]。此外,法舒地尔诱导肌动蛋白应力纤维的解体和细胞迁移抑制[4]。法舒地尔抑制肝星状细胞扩散,应激纤维的形成和α-SMA的表达,同时抑制细胞生长,但不诱导细胞凋亡。法舒地尔还阻断了LPA诱导的ERK1/2,JNK和p38 MAPK的磷酸化[5]。

[体内研究]

法舒地尔(30μg)通过冠状动脉内注射给狗增加了50％的CBF。法舒地尔(0.01,0.03,0.1和0.3 mg/kg,推注,静脉注射)可降低MBP并增加HR,VBF,CBF,RBF和FBF。法舒地尔(1.0 ng/mL)可增加心输出量。法舒地尔通过静脉注射导致MBP,左心室收缩压和总外周阻力显着下降,HR和心输出量增加,但对右心房压,dP/dt或左心室分钟工作没有明显影响[3]。法舒地尔对心血管疾病具有可保护作用,减少JNK的激活,减轻缺血性损伤后AIF的线粒体-核转位[6]。法舒地尔(100mg/kg /天,口服)显着降低用PLP p139-151免疫的SJL/J小鼠的EAE的发生率和平均最大临床评分。法舒地尔抑制脾细胞对小鼠抗原的增殖反应。法舒地尔通过口服给药减少法舒地尔治疗小鼠的炎症,脱髓鞘,轴突缺失和脊髓APP阳性[7]。

[激酶实验]

在含有最终体积0.2mL，50mM Tris-HCl（pH 7.0），10mM乙酸镁，2mM EGTA，1μM环AMP或不含环状的反应混合物中测定环AMP依赖性蛋白激酶活性。 AMP，3.3至20μM[r-32P] ATP（4×105cpm），0.5μg酶，100μg组蛋白H2B和化合物。将混合物在30℃下孵育5分钟。加入500μg牛血清白蛋白作为载体蛋白后，加入1mL冰冷的20％三氯乙酸终止反应。将样品以3000rpm离心15分钟，将沉淀重悬于冰冷的10％三氯乙酸溶液中，并将离心 - 再悬浮循环重复三次。将最终的沉淀溶解在1mL的1N NaOH中，并用液体闪烁计数器测量放射性。

[参考文献]

[1]. Ono-Saito N, et al. H-series protein kinase inhibitors and potential clinical applications. Pharmacol Ther. 1999 May-Jun;82(2-3):123-31.

[2]. Asano T, et al. Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther. 1987 Jun;241(3):1033-40.

[3]. Asano T, et al. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol. 1989 Dec;98(4):1091-100.

[4]. Negoro N, et al. The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells. Biochem Biophys Res Commun. 1999 Aug 19;262(1):211-5.

[5]. Fukushima M, et al. Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells. Liver Int. 2005 Aug;25(4):829-38.

[6]. Zhang J, et al. Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation. Clin Chim Acta. 2009 Mar;401(1-2):76-80.

[7]. Sun X, et al. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2006 Nov;180(1-2):126-34

[8]. Uehata M, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997 Oct 30;389(6654):990-4.

[相关活性小分子]

盐酸法舒地尔物理化学性质

[ 沸点 ]:
506.2ºC at 760 mmHg

[ 熔点 ]:
222 °C(dec.)

[ 分子式 ]:
C₁₄H₁₈ClN₃O₂S

[ 分子量 ]:
327.83

[ 闪点 ]:
259.9ºC

[ PSA ]:
70.68000

[ LogP ]:
4.17030

[ 外观性状 ]:
白色固体

[ 储存条件 ]:
室温，干燥

[ 水溶解性 ]:
H2O: >200 mg/mL

盐酸法舒地尔MSDS

详细MSDS(安全技术说明书)

盐酸法舒地尔毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: HM4033500

CHEMICAL NAME :: 1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)-, monohydrochloride

CAS REGISTRY NUMBER :: 105628-07-7

LAST UPDATED :: 199612

DATA ITEMS CITED :: 12

MOLECULAR FORMULA :: C14-H17-N3-O2-S.Cl-H

MOLECULAR WEIGHT :: 327.86

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 335 mg/kg

TOXIC EFFECTS :: Sense Organs and Special Senses (Eye) - ptosis Behavioral - tremor Behavioral - convulsions or effect on seizure threshold

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 20(Suppl 6),S1433,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 123 mg/kg

TOXIC EFFECTS :: Sense Organs and Special Senses (Eye) - ptosis Behavioral - tremor Behavioral - convulsions or effect on seizure threshold

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 20(Suppl 6),S1433,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 59900 ug/kg

TOXIC EFFECTS :: Sense Organs and Special Senses (Eye) - ptosis Behavioral - convulsions or effect on seizure threshold Gastrointestinal - changes in structure or function of salivary glands

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 20(Suppl 6),S1433,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 274 mg/kg

TOXIC EFFECTS :: Sense Organs and Special Senses (Eye) - ptosis Behavioral - altered sleep time (including change in righting reflex) Behavioral - convulsions or effect on seizure threshold

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 20(Suppl 6),S1433,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 124 mg/kg

TOXIC EFFECTS :: Sense Organs and Special Senses (Eye) - ptosis Behavioral - altered sleep time (including change in righting reflex) Behavioral - convulsions or effect on seizure threshold

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 20(Suppl 6),S1433,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 67600 ug/kg

TOXIC EFFECTS :: Sense Organs and Special Senses (Eye) - ptosis Behavioral - convulsions or effect on seizure threshold Behavioral - Straub tail

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 20(Suppl 6),S1433,1992

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Primate - monkey

DOSE/DURATION :: 20 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 26,740,1995 ** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 700 mg/kg/28D-C

TOXIC EFFECTS :: Kidney, Ureter, Bladder - changes in bladder weight Blood - pigmented or nucleated red blood cells Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 20(Suppl 6),S1441,1992 ** REPRODUCTIVE DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intravenous

DOSE :: 2100 mg/kg

SEX/DURATION :: male 9 week(s) pre-mating female 2 week(s) pre-mating - 7 day(s) after conception

TOXIC EFFECTS :: Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - other measures of fertility

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 22,41,1994

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intravenous

DOSE :: 440 mg/kg

SEX/DURATION :: female 7-17 day(s) after conception

TOXIC EFFECTS :: Reproductive - Maternal Effects - parturition Reproductive - Specific Developmental Abnormalities - musculoskeletal system

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 20(Suppl 6),S1469,1992

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intravenous

DOSE :: 440 mg/kg

SEX/DURATION :: female 7-17 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain) Reproductive - Effects on Newborn - behavioral Reproductive - Effects on Newborn - physical

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 20(Suppl 6),S1469,1992

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intravenous

DOSE :: 1 gm/kg

SEX/DURATION :: female 17-20 day(s) after conception lactating female 21 day(s) post-birth

TOXIC EFFECTS :: Reproductive - Maternal Effects - other effects Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)

REFERENCE :: YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 22,61,1994

盐酸法舒地尔安全信息

[ 危害码 (欧洲) ]:
Xi

[ WGK德国 ]:
3

[ RTECS号 ]:
HM4031166

[ 海关编码 ]:
2942000000

盐酸法舒地尔合成路线

详细合成路线

盐酸法舒地尔上下游产品

盐酸法舒地尔上游产品

盐酸法舒地尔下游产品

盐酸法舒地尔海关

[ 海关编码 ]: 2933990090

[ 中文概述 ]:
2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%